A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia
Author:
Megan A. Bohensky,Kumar Pasupathi,Alexandra Gorelik,Hansoo Kim,James P. Harrison,Danny Liew
Publication:
Value in Health
© 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.